In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii

Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections

(2010) Anjali N. Kunz et al.   CHEMOTHERAPY

Treatment ofAcinetobacterInfections

(2010) Joel Fishbain et al.   CLINICAL INFECTIOUS DISEASES

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control

(2010) Y. Carmeli et al.   CLINICAL MICROBIOLOGY AND INFECTION

Emerging carbapenemases: a global perspective

(2010) Timothy R. Walsh   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices

(2009) James H. Jorgensen et al.   CLINICAL INFECTIOUS DISEASES

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii

(2009) Luigi Principe et al.   Annals of Clinical Microbiology and Antimicrobials

Tigecycline for the Treatment of Acinetobacter Infections: A Case Series

(2008) Jason C Gallagher et al.   ANNALS OF PHARMACOTHERAPY

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites

(2008) D. Gur et al.   JOURNAL OF MEDICAL MICROBIOLOGY